Raphael Teipel

5PUBLICATIONS

65CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursRegenerative medicine (incl. stem cells)Medical devicesTransplantation immunology

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (5)

Sort by Publication Date:

|Jun 12, 2026

Outcomes of CAR-T Cell Therapy and Bispecific Antibodies as Single-Modality and Sequential Strategies in Relapsed/Refractory Multiple Myeloma.

|Feb 13, 2026

Clinical Scores to Predict Toxicities and Outcomes in Patients with Multiple Myeloma Undergoing Bispecific T-cell Engager Therapy.

Jan H Frenking, Christine Riedhammer, Thomas Hielscher

|Feb 25, 2025

Is there still a place for autologous salvage transplantation in relapsed/refractory multiple myeloma in the era of novel therapies?

Simone Karp, Karolin Trautmann-Grill, Paul Warncke

|Mar 12, 2024

Successful treatment of scleromyxoedema with daratumumab.

Katharina Epp, Raphael Teipel, Ulrike Reuner

|Mar 13, 2018

Anti-CD20 immunotherapy as a bridge to tolerance, after allogeneic stem cell transplantation for patients with chronic lymphocytic leukaemia: results of the CLLX4 trial.

Johannes Schetelig, Cornelia S Link, Gernot Stuhler

Pageof 1

Frequent Collaborators

Johannes Schetelig

Katharina Epp

Mathias Hänel

Jan H Frenking

Christine Riedhammer

Thomas Hielscher

Christoph Schaefers

Lisa B Leypoldt

Marie Harzer

David Sedloev

Frequent Collaborators

Johannes Schetelig

Katharina Epp

Mathias Hänel

Jan H Frenking